ADC Therapeutics is a biopharmaceuticals company developing a pipeline of anti-cancer products based on antibody drug conjugation technology. ADC Therapeutics floated on NYSE in May 2020.

Bango is a mobile payments and analytics service provider. Bango floated on AIM on 30 June 2005 – EPIC code BGO.

Carbon Engineering is a global pioneer in DAC (direct-air-capture) removing CO2 directly from the atmosphere for sequestration or recycling. Carbon Engineering was acquired by Occidental Petroleum for $1.1B in August 2023.

Cambridge Display Technology develops and supplies proprietary materials for OLED displays based on technology developed at the Cavendish Laboratory. CDT floated on NASDAQ in December 2004 and has since been acquired by Sumitomo Chemcial Co Ltd.

Equitalk is a low cost web-based telephony provider. Equitalk was acquired by Xfone Inc in July 2006.

Infyos enables e-vehicle makers, battery manufacturers and miners to map and measure the impact & efficiency of their supply chain to improve performance and reduce risk​.

Materials Nexus is revolutionising the discovery and development of low-carbon sustainable materials. The initial focus is on using novel alloys and ceramics to develop high-strength, light-weight recyclable materials to replace steel in the automotive industry.

Phico is a therapeutic biotechnology company developing treatments for multiply resistant bacteria.

Plastic Logic develops and manufactures printable, flexible plastic semiconductors, exploiting technology developed at the Cavdendish Laboratory in the University of Cambridge.

PuriFire Labs is delivering sustainable green hydrogen and methanol solutions by transforming waste carbon and water or wastewater using a process that does not depend on electrolysis and can exploit waste heat from industry or agriculture.

Signify is an authentication and identity management service provider. Signify was acquired by Accumuli plc (now part of NCC plc) in June 2013.

Silicon Fuel has developed a unique nanomaterial which generates hydrogen via reaction with water, enabling safe and efficient hydrogen storage for power generation through fuel cells.

Solcom develops systems for controlling advanced medical processes, particularly nuclear medicine. QTP, a fund managed by ETCapital, sold its interest in Solcom in October 2008.

Spirogen develops complex molecules and a platform technology for antibody drug conjugation being utilised in innovative anti cancer therapies. Spirogen was acquired by AstraZeneca in November 2013.